Asia
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
The WHO panel recommends adopting global standards, giving structure to prevent the unscrupulous, inequitable, and possibly dangerous uses of CRISPR technology.
Sparx Therapeutics is expanding its operations into Yangzhou, China, with the imminent construction of a 1.2 million square foot facility for its commercial production.
Sinovac’s CoronaVac was the first COVID-19 vaccine approved in China for emergency use back in June 2020.
The vaccine demonstrated efficacy in mild, moderate, and severe COVID-19 of 77.8% with efficacy against severe disease of 93.4%.
With business taking him throughout North and South America, Asia, and Europe, he’s learned to adapt and appreciate the nuances of a multicultural environment.
It was another busy week for clinical trial news ahead of the July 4 holiday in the U.S. Here’s a look.
The vaccine, dubbed ZyCoV-D, will be the first DNA vaccine available in the world if authorized by regulators.
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
Every week there are numerous scientific studies published. This week there was an unusual number of research stories revolving around Alzheimer’s disease. Here’s a look at some of the more interesting ones.
PRESS RELEASES